RESUMO
A major genetic risk factor for psychosis is 22q11.2 deletion (22q11.2DS). However, robust and replicable functional brain signatures of 22q11.2DS and 22q11.2DS-associated psychosis remain elusive due to small sample sizes and a focus on small single-site cohorts. Here, we identify functional brain signatures of 22q11.2DS and 22q11.2DS-associated psychosis, and their links with idiopathic early psychosis, using one of the largest multi-cohort data to date. We obtained multi-cohort clinical phenotypic and task-free fMRI data from 856 participants (101 22q11.2DS, 120 idiopathic early psychosis, 101 idiopathic autism, 123 idiopathic ADHD, and 411 healthy controls) in a case-control design. A novel spatiotemporal deep neural network (stDNN)-based analysis was applied to the multi-cohort data to identify functional brain signatures of 22q11.2DS and 22q11.2DS-associated psychosis. Next, stDNN was used to test the hypothesis that the functional brain signatures of 22q11.2DS-associated psychosis overlap with idiopathic early psychosis but not with autism and ADHD. stDNN-derived brain signatures distinguished 22q11.2DS from controls, and 22q11.2DS-associated psychosis with very high accuracies (86-94%) in the primary cohort and two fully independent cohorts without additional training. Robust distinguishing features of 22q11.2DS-associated psychosis emerged in the anterior insula node of the salience network and the striatum node of the dopaminergic reward pathway. These features also distinguished individuals with idiopathic early psychosis from controls, but not idiopathic autism or ADHD. Our results reveal that individuals with 22q11.2DS exhibit a highly distinct functional brain organization compared to controls. Additionally, the brain signatures of 22q11.2DS-associated psychosis overlap with those of idiopathic early psychosis in the salience network and dopaminergic reward pathway, providing substantial empirical support for the theoretical aberrant salience-based model of psychosis. Collectively, our findings, replicated across multiple independent cohorts, advance the understanding of 22q11.2DS and associated psychosis, underscoring the value of 22q11.2DS as a genetic model for probing the neurobiological underpinnings of psychosis and its progression.
RESUMO
Subtle alterations in white matter microstructure are observed in youth at clinical high risk (CHR) for psychosis. However, the timing of these changes and their relationships to the emergence of psychosis remain unclear. Here, we track the evolution of white matter abnormalities in a large, longitudinal cohort of CHR individuals comprising the North American Prodrome Longitudinal Study (NAPLS-3). Multi-shell diffusion magnetic resonance imaging data were collected across multiple timepoints (1-5 over 1 year) in 286 subjects (aged 12-32 years): 25 CHR individuals who transitioned to psychosis (CHR-P; 61 scans), 205 CHR subjects with unknown transition outcome after the 1-year follow-up period (CHR-U; 596 scans), and 56 healthy controls (195 scans). Linear mixed effects models were fitted to infer the impact of age and illness-onset on variation in the fractional anisotropy of cellular tissue (FAT) and the volume fraction of extracellular free water (FW). Baseline measures of white matter microstructure did not differentiate between HC, CHR-U and CHR-P individuals. However, age trajectories differed between the three groups in line with a developmental effect: CHR-P and CHR-U groups displayed higher FAT in adolescence, and 4% lower FAT by 30 years of age compared to controls. Furthermore, older CHR-P subjects (20+ years) displayed 4% higher FW in the forceps major (p < 0.05). Prospective analysis in CHR-P did not reveal a significant impact of illness onset on regional FAT or FW, suggesting that transition to psychosis is not marked by dramatic change in white matter microstructure. Instead, clinical high risk for psychosis-regardless of transition outcome-is characterized by subtle age-related white matter changes that occur in tandem with development.
Assuntos
Transtornos Psicóticos , Substância Branca , Adolescente , Adulto , Criança , Pré-Escolar , Corpo Caloso/patologia , Humanos , Estudos Longitudinais , Sintomas Prodrômicos , Transtornos Psicóticos/patologia , Substância Branca/patologia , Adulto JovemRESUMO
Schizophrenia (SCZ) is a disabling neuropsychiatric disease associated with disruptions across distributed neural systems. Resting-state functional magnetic resonance imaging has identified extensive abnormalities in the blood-oxygen level-dependent signal in SCZ patients, including alterations in the average signal over the brain-i.e. the "global" signal (GS). It remains unknown, however, if these "global" alterations occur pervasively or follow a spatially preferential pattern. This study presents the first network-by-network quantification of GS topography in healthy subjects and SCZ patients. We observed a nonuniform GS contribution in healthy comparison subjects, whereby sensory areas exhibited the largest GS component. In SCZ patients, we identified preferential GS representation increases across association regions, while sensory regions showed preferential reductions. GS representation in sensory versus association cortices was strongly anti-correlated in healthy subjects. This anti-correlated relationship was markedly reduced in SCZ. Such shifts in GS topography may underlie profound alterations in neural information flow in SCZ, informing development of pharmacotherapies.
Assuntos
Encéfalo/fisiopatologia , Esquizofrenia/fisiopatologia , Adulto , Encéfalo/diagnóstico por imagem , Mapeamento Encefálico , Circulação Cerebrovascular/fisiologia , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Vias Neurais/diagnóstico por imagem , Vias Neurais/fisiopatologia , Oxigênio/sangue , Descanso , Esquizofrenia/diagnóstico por imagemRESUMO
Converging evidence suggests that major depressive disorder (MDD) affects multiple large-scale brain networks. Analyses of the correlation or covariance of regional brain structure and function applied to structural and functional MRI data may provide insights into systems-level organization and structure-to-function correlations in the brain in MDD. This study applied tensor-based morphometry and intrinsic connectivity distribution to identify regions of altered volume and intrinsic functional connectivity in data from unmedicated individuals with MDD (n=17) and healthy comparison participants (HC, n=20). These regions were then used as seeds for exploratory anatomical covariance and connectivity analyses. Reduction in volume in the anterior cingulate cortex (ACC) and lower structural covariance between the ACC and the cerebellum were observed in the MDD group. Additionally, individuals with MDD had significantly lower whole-brain intrinsic functional connectivity in the medial prefrontal cortex (mPFC). This mPFC region showed altered connectivity to the ventral lateral PFC (vlPFC) and local circuitry in MDD. Global connectivity in the ACC was negatively correlated with reported depressive symptomatology. The mPFC-vlPFC connectivity was positively correlated with depressive symptoms. Finally, we observed increased structure-to-function correlation in the PFC/ACC in the MDD group. Although across all analysis methods and modalities alterations in the PFC/ACC were a common finding, each modality and method detected alterations in subregions belonging to distinct large-scale brain networks. These exploratory results support the hypothesis that MDD is a systems level disorder affecting multiple brain networks located in the PFC and provide new insights into the pathophysiology of this disorder.
Assuntos
Transtorno Depressivo Maior/fisiopatologia , Imagem de Tensor de Difusão/métodos , Vias Neurais/fisiopatologia , Adolescente , Adulto , Estudos de Casos e Controles , Cerebelo/anatomia & histologia , Cerebelo/fisiologia , Feminino , Giro do Cíngulo/anatomia & histologia , Giro do Cíngulo/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Neuroimagem , Córtex Pré-Frontal/fisiologia , Adulto JovemRESUMO
Emerging behavioral and neuroimaging studies in schizophrenia (SCZ) and major depressive disorder (MD) are mapping mechanisms of co-occurring and distinct affective disturbances across these disorders. This constitutes a critical goal towards developing rationally guided therapies for upstream neural pathways that contribute to comorbid symptoms across disorders. We highlight the current state of the art in our understanding of emotional dysregulation in SCZ versus MD by focusing on broad domains of behavioral function that can map onto underlying neural systems, namely deficits in hedonics, anticipatory behaviors, computations underlying value and effort, and effortful goal-directed behaviors needed to pursue rewarding outcomes. We highlight unique disturbances in each disorder that may involve dissociable neural systems, but also possible interactions between affect and cognition in MD versus SCZ. Finally, we review computational and translational approaches that offer mechanistic insight into how cellular-level disruptions can lead to complex affective disturbances, informing development of therapies across MD and SCZ.
Los nuevos estudios conductuales y de neuroimágenes en la esquizofrenia (EQZ) y en el trastorno depresivo mayor (TDM) permiten mapear las alteraciones afectivas concomitantes y específicas en estos trastornos. Esto constituye un objetivo fundamental para el desarrollo racional de terapias que actùen a nivel de las vías neurales ascendentes que contribuyen a los síntomas comórbidos en estos trastornos. Se pone de relieve el conocimiento actual del arte acerca del conocimiento de la desregulación emocional en la EQZ versus el TDM al centrarse en grandes areas del funcionamiento conductual que puedan mapear los sistemas neurales subyacentes, como los déficits en la hedónica, las conductas anticipatorias, los cálculos implícitos al valor y al esfuerzo, y las conductas dirigidas a un objetivo que requieren de un necesario esfuerzo para perseguir resultados gratificantes. Se destacan las alteraciones características en cada trastorno que pueden involucrar sistemas neurales disociables, como también posibles interacciones entre afecto y cognición en el TDM versus la EQZ. Por último se revisan enfoques computacionales y translacionales que ofrecen visiones mecanicistas de cómo las alteraciones a nivel celular pueden llevar a complejas alteraciones afectivas, que inspiren el desarrollo de terapias para el TDM y la EQZ.
Les nouvelles études de comportement et de neuro-imagerie dans la schizophrénie (SCZ) et le trouble dépressif caractérisé (TDC) permettent de cartographier les perturbations affectives concomitantes ou particulières de ces maladies. C'est un enjeu essentiel du développement rationnel des traitements agissant sur les voies neuronales d'amont qui contribuent aux symptômes comorbides de ces troubles. Nous soulignons l'état actuel des techniques de compréhension du dérèglement émotionnel dans la SCZ versus le TDC en insistant sur les vastes domaines du fonctionnement comportemental qui peuvent être identifiés sur les cartographies des systèmes neuronaux sous-jacents, c'est-a-dire les déficits des comportements hédoniques et anticipatoires, les calculs sous-tendant la valeur et l'effort, ainsi que les comportements volontaires orientes vers un but, nécessaires a la poursuite de résultats gratifiants. Nous soulignons les perturbations particulières de chaque trouble, qui peuvent impliquer des systèmes neuronaux dissociables, mais aussi d'éventuelles interactions entre l'affect et la cognition dans le TDC versus la SCZ. Enfin, nous examinons les approches informatiques et translationnelles qui proposent une vision mécaniste de la façon dont les perturbations au niveau cellulaire peuvent induire des troubles affectifs complexes, influant sur le développement des traitements pour le TDC et la SCZ.